During a hyperglycaemic clamp in T2D patients, GIP infusion led to a reduction in mean arterial blood pressure (10–15 mmHg) and increase in heart rate (~8 bpm) [4]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.